A Federal Pause in Potentially Risky Influenza Research

First Page		Document Content
Date: 2014-11-26 12:59:04 Biosecurity National Institutes of Health Influenza research Influenza A virus subtype H5N1 Influenza National Institute of Allergy and Infectious Diseases Centers for Disease Control and Prevention Medicine Health Research		A Federal Pause in Potentially Risky Influenza Research Add to Reading List Source URL: www.fas.org Download Document from Source Website File Size: 54,94 KB Share Document on Facebook

	National Institute of Allergy and Infectious Diseases Awards MERS/SARS Coronavirus Drug Research Grant to Autoimmune Technologies FOR IMMEDIATE RELEASE New Orleans, June 24, Autoimmune Technologies LLC, a New Orle DocID: 1uTGp - View Document
	Emerging and Re-emerging Infectious Diseases developed under a contract from the National Institutes of Health in collaboration with the National Institute of Allergy and Infectious Diseases DocID: 1uoM7 - View Document
	Sanaria® PfSPZ Malaria Vaccine Wins 2014 Vaccine Industry Excellence Award for “Best Prophylactic Vaccine” Rockville, MD - Sanaria received the 2014 Vaccine Industry Excellence Award for the “Best Prophylactic Vac DocID: 1rm3H - View Document
	Off i ce O f C l i nic al S it e Oversight National Institute of Allergy and Infectious Diseases (NIAID) MOB Report 4th Edition DocID: 1qxvn - View Document
	Research Conducted and Supported by the National Institutes of Health (NIH) in Addressing Zika Virus Disease. Testimony before the DocID: 1qsO1 - View Document